[Serum HBV-DNA level can predict treatment effectiveness in patients with chronic hepatitis B using interferon-alpha-2a].

Objective: To evaluate the correlation between the efficacy of interferon-alpha-2a and the kinetics of viral load in serum.

Methods: The authors conducted a trial including 58 patients with chronic hepatitis B. Patients were treated with interferon-alpha-2a three times a week for 6 months.